CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Planned sale EVP and Chief Medical Officer sold 2,089 shares at $7.45 ($15,569)
- 4 Planned sale EVP, General Counsel, Corp Sec sold 4,445 shares at $7.45 ($33,128)
- 4 Planned sale Chief Executive Officer sold 19,039 shares at $7.45 ($141,894)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 424B5 Offering Prospectus
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Material agreement · Results of operations · Unregistered share sale · Other events
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale SVP, Chief Accounting Officer sold 1,530 shares at $7.79 ($11,919)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
Page 5 of 41 · 806 filings